XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2021   88,305      
Beginning balance at Dec. 31, 2021 $ 90,823 $ 9 $ 492,512 $ (32,985) $ (368,713)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock based compensation 1,777   1,777    
Issuance of restricted stock (in shares)   (61)      
Issuance of restricted stock 0        
Preferred stock dividend (2,438)   (2,438)    
Net income (loss) attributable to Synchronoss (3,037)       (3,037)
Non-controlling interest 0   115   (115)
Total other comprehensive income (loss) (3,141)     (3,141)  
Ending balance (in shares) at Mar. 31, 2022   88,244      
Ending balance at Mar. 31, 2022 $ 83,984 $ 9 491,966 (36,126) (371,865)
Beginning balance (in shares) at Dec. 31, 2022 90,853 90,853      
Beginning balance at Dec. 31, 2022 $ 68,097 $ 9 488,848 (44,131) (376,629)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock based compensation 1,314   1,314    
Issuance of restricted stock (in shares)   2,695      
Issuance of restricted stock 0        
Preferred stock dividend (2,474)   (2,474)    
Shares withheld for taxes in connection with issuance of restricted stock (in shares)   (1)      
Shares withheld for taxes in connection with issuance of restricted stock (1)   (1)    
Net income (loss) attributable to Synchronoss (10,931)       (10,931)
Non-controlling interest 0   (14)   14
Total other comprehensive income (loss) $ 4,570     4,570  
Ending balance (in shares) at Mar. 31, 2023 93,547 93,547      
Ending balance at Mar. 31, 2023 $ 60,575 $ 9 $ 487,673 $ (39,561) $ (387,546)